Announcements Trials
Browse Landscape

Phase

Phase 2 46Phase 1 11Phase 1/2 6Phase NA 2Phase 4 2Phase 2/3 2Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 7OTHER_GOV 1OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Ameloblastoma 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × OTHER × dabrafenib × Clear all
NCT06264778 2024-02-20

Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma

Shandong University

Phase 3 Unknown
10 enrolled

Ameloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡